[go: up one dir, main page]

IL139311A0 - Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis - Google Patents

Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis

Info

Publication number
IL139311A0
IL139311A0 IL13931199A IL13931199A IL139311A0 IL 139311 A0 IL139311 A0 IL 139311A0 IL 13931199 A IL13931199 A IL 13931199A IL 13931199 A IL13931199 A IL 13931199A IL 139311 A0 IL139311 A0 IL 139311A0
Authority
IL
Israel
Prior art keywords
neisseria
containing recombinant
vaccines containing
recombinant pilin
gonorrhoeae
Prior art date
Application number
IL13931199A
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL139311A0 publication Critical patent/IL139311A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13931199A 1998-04-29 1999-04-29 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis IL139311A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8340598P 1998-04-29 1998-04-29
PCT/US1999/009486 WO1999055875A2 (en) 1998-04-29 1999-04-29 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS)

Publications (1)

Publication Number Publication Date
IL139311A0 true IL139311A0 (en) 2001-11-25

Family

ID=22178094

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13931199A IL139311A0 (en) 1998-04-29 1999-04-29 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis

Country Status (9)

Country Link
EP (1) EP1073748A2 (en)
JP (1) JP2002527041A (en)
KR (4) KR20060118630A (en)
CN (1) CN1245512C (en)
AU (2) AU3968599A (en)
BR (1) BR9910005A (en)
CA (1) CA2325055A1 (en)
IL (1) IL139311A0 (en)
WO (1) WO1999055875A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
WO2005098028A1 (en) * 2004-04-08 2005-10-20 The State Of Queensland Acting Through Its Department Of Health Neisseria gonorrhoeae detection
US20110182981A1 (en) * 2008-08-25 2011-07-28 Peixuan Zhu Gonococcal vaccines
US9802988B2 (en) * 2009-05-20 2017-10-31 University Of Maryland, Baltimore Engineered type IV pilin of Clostridium difficile
WO2012059593A1 (en) * 2010-11-05 2012-05-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccines for preventing meningococcal infections
JP5991740B2 (en) * 2012-06-21 2016-09-14 キヤノン株式会社 License management apparatus, license management method, and program
AU2013295242C1 (en) * 2012-07-27 2018-08-09 Institut National De La Sante Et De La Recherche Medicale CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
CN103405760A (en) * 2013-06-19 2013-11-27 中国科学院海洋研究所 Application of edwardsiella tarda pilin FimA
CN106290849A (en) * 2015-05-13 2017-01-04 上海凯创生物技术有限公司 A kind of meningitis bacterium gold-immunochromatographyreagent reagent for assay box
CN118994336B (en) * 2024-10-22 2025-01-24 四川大学华西医院 Recombinant protein antigen of Acinetobacter baumannii fimbriae, preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1549345A (en) * 1975-04-25 1979-08-08 Bactex Inc Gonococcal pili processes for the preparation thereof and the use thereof
EP0049945A3 (en) * 1980-09-15 1982-12-01 Bactex Incorporated Determining a hierarchy of piliated organisms and a vaccine prepared from such organisms
US4443431A (en) * 1981-05-27 1984-04-17 The United States Of America As Represented By The Department Of Health And Human Services Neisseria gonorrhoeae vaccine
JPS61501777A (en) * 1984-04-06 1986-08-21 スクリツプス　クリニツク　アンド　リサ−チ　フアウンデ−シヨン Peptide vaccines or diagnostic systems and potent polypeptides therefor
CU22302A1 (en) * 1990-09-07 1995-01-31 Cigb Codifying nucleotidic sequence for a protein of the external membrane of neisseria meningitidis and the use of that protein in preparing vaccines.
AU1411492A (en) * 1991-01-31 1992-09-07 Washington University Polypeptides and polynucleotides useful for the diagnosis and treatment of pathogenic neisseria
AU3416693A (en) * 1991-12-18 1993-07-19 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University, The Antigenic preparations that stimulate production of antibodies which bind to the pili of type IV piliated bacteria
CA2138997C (en) * 1992-06-25 2003-06-03 Jean-Paul Prieels Vaccine composition containing adjuvants
AU5403594A (en) * 1992-10-07 1994-04-26 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Pilin variants and uses thereof
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule

Also Published As

Publication number Publication date
CA2325055A1 (en) 1999-11-04
AU3968599A (en) 1999-11-16
WO1999055875A3 (en) 2000-04-13
BR9910005A (en) 2001-01-16
KR20060118630A (en) 2006-11-23
AU2003204738B2 (en) 2006-09-14
KR20010043105A (en) 2001-05-25
CN1245512C (en) 2006-03-15
JP2002527041A (en) 2002-08-27
EP1073748A2 (en) 2001-02-07
KR20060118629A (en) 2006-11-23
WO1999055875A2 (en) 1999-11-04
CN1298446A (en) 2001-06-06
KR20060118628A (en) 2006-11-23

Similar Documents

Publication Publication Date Title
PT2275552E (en) Neisserial antigenic peptides
GB0023008D0 (en) Improvements in vaccination
HUP9901160A3 (en) Mouth piece for delivering medicine, especially comforter and a piece for such a mouth piece
AU5426098A (en) Invasion associated genes from (neisseria meningitidis) serogroup
GB9820784D0 (en) Improvements in or relating tp hypodermic syringes
IL138457A0 (en) Bi-cortical dental implant
IL148713A0 (en) Oral recombinant lactobacilli vaccines
IL139311A0 (en) Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis
AU2003204738A1 (en) Vaccines Containing Recombinant Pilin Against Neisseria Gonorrhoeae or Neisseria Meningitidis
IL189736A0 (en) Vaccine adjuvants
HUP0105430A3 (en) Attenuated bacteria and vaccines containing thereof
AU2289000A (en) (neisseria meningitidis) polypeptide basb052
HUP9801714A3 (en) Neisseria meningitidis subunit tbp2
GB9611673D0 (en) Meningococcal vaccine
GB9601614D0 (en) Dental or medical appliance
HUP0002228A3 (en) Line attenuated bacteria for use in a vaccine
GB2344590B (en) Attenuated poliovirus vaccine
AU1780300A (en) Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides
AU2107400A (en) Neisseria meningitidis antigen
AU2439300A (en) Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
GB2327604B (en) Medical duvet
AU2546600A (en) Neisseria meningitidis serogroup b antigen
AU5617698A (en) Immunization against (neisseria gonorrhoeae) and (neisseria meningitidis)
GB9718616D0 (en) Oral vaccine
ZA200000142B (en) Adjuvants for use in vaccines.